scholarly journals Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial

2019 ◽  
Vol 14 (5) ◽  
pp. 867-875 ◽  
Author(s):  
Yi-Long Wu ◽  
Shun Lu ◽  
Ying Cheng ◽  
Caicun Zhou ◽  
Jie Wang ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document